Biological Psychiatry
Volume 66, Issue 3 , Pages 275-282, 1 August 2009

Increased Vulnerability to Depressive-Like Behavior of Mice with Decreased Expression of VGLUT1

  • Alvaro L. Garcia-Garcia

      Affiliations

    • Department of Pharmacology, University of Navarra, Pamplona, Spain
  • ,
  • Natalia Elizalde

      Affiliations

    • Department of Pharmacology, University of Navarra, Pamplona, Spain
  • ,
  • Denis Matrov

      Affiliations

    • Department of Psychology, Estonian Centre of Behavioural and Health Sciences, University of Tartu, Tartu, Estonia
  • ,
  • Jaanus Harro

      Affiliations

    • Department of Psychology, Estonian Centre of Behavioural and Health Sciences, University of Tartu, Tartu, Estonia
  • ,
  • Sonja M. Wojcik

      Affiliations

    • Abteilung Molekulare Neurobiologie, Max-Planck-Institut für Experimentelle Medizin, Göttingen, Germany
  • ,
  • Elisabet Venzala

      Affiliations

    • Department of Pharmacology, University of Navarra, Pamplona, Spain
  • ,
  • Maria J. Ramírez

      Affiliations

    • Department of Pharmacology, University of Navarra, Pamplona, Spain
  • ,
  • Joaquin Del Rio

      Affiliations

    • Department of Pharmacology, University of Navarra, Pamplona, Spain
    • Centro investigacíon biomedíca en Red para enfermedades neurodegenerativas (CIBERNED), Spain
  • ,
  • Rosa M. Tordera

      Affiliations

    • Department of Pharmacology, University of Navarra, Pamplona, Spain
    • Corresponding Author InformationAddress reprint requests to Rosa Tordera, Ph.D., Department of Pharmacology, University of Navarra, 31080 Pamplona, Spain

Received 25 November 2008; received in revised form 11 February 2009; accepted 19 February 2009. published online 04 May 2009.

Background

Many studies link depression to an increase in the excitatory–inhibitory ratio in the forebrain. Presynaptic alterations in a shared pathway of the glutamate/gamma-aminobutyric acid (GABA) cycle may account for this imbalance. Evidence suggests that decreased vesicular glutamate transporter 1 (VGLUT1) levels in the forebrain affect the glutamate/GABA cycle and induce helpless behavior. We studied decreased VGLUT1 as a potential factor enhancing a depressive-like phenotype in an animal model.

Methods

Glutamate and GABA synthesis as well as oxidative metabolism were studied in heterozygous mice for the VGLUT1+/– and wildtype. The regulation of neurotransmitter levels, proteins involved in the glutamate/GABA cycle, and behavior by both genotype and chronic mild stress (CMS) were studied. Finally, the effect of chronic imipramine on VGLUT1 control and CMS mice was studied.

Results

VGLUT1+/– mice showed increased neuronal synthesis of glutamate; decreased cortical and hippocampal GABA, VGLUT1, and excitatory amino acid transporter 1 (EAAT1) as well as helplessness and anhedonia. CMS induced an increase of glutamate and a decrease of GABA, the vesicular GABA transporter (VGAT), and glutamic acid decarboxylase 65 (GAD65) in both areas and led to upregulation of EAAT1 in the hippocampus. Moreover, CMS induced anhedonia, helplessness, anxiety, and impaired recognition memory. VGLUT1+/– CMS mice showed a combined phenotype (genotype plus stress) and specific alterations, such as an upregulation of VGLUT2 and hyperlocomotion. Moreover, an increased vulnerability to anhedonia and helplessness reversible by chronic imipramine was shown.

Conclusions

These studies highlight a crucial role for decreased VGLUT1 in the forebrain as a biological mediator of increased vulnerability to chronic mild stress.

Key Words: Chronic mild stress, GABA, glutamate, major depression, vesicular glutamate transporters, VGLUT2

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0006-3223(09)00294-7

doi:10.1016/j.biopsych.2009.02.027

Biological Psychiatry
Volume 66, Issue 3 , Pages 275-282, 1 August 2009